Germany The price of EUR 5 sildenafil.

The international jury praised Balkwill for ‘ her spectacular work in communicating important scientific concepts to the young and their tireless efforts to bring critical science and health news disadvantaged communities. In Heidelberg, Germany – The price of EUR 5,000 and a handmade gold and silver medals were Fran Balkwill on 5 November 2004 in the EMBL / EMBO Science & Society Conference . Introduced mechanisms and significance of Time and Aging sildenafil .

Contacts:EMBO EMBO Lindsay Johnson Communications Officer PO Box 102240 D – 69012 Heidelberg Germany Phone: 49-6221-8891-108 Fax: 49-6221-8891-200Queen Mary School of Medicine and Dentistry Sally Webster Deputy Head of Press & PR External Relations & Communications Department Queen Mary, University of London, Mile End Road, London E1 4NS England Tel.

### – Required Medicines Australia businesses to working together with of the Australian Government make sure that Australia health care system will in patient choice and universal access, one of the finest in the world .

Safe Harbor Statement: This press release contains forward-looking looking statements regarding the time and financial consequences of Milestone ‘s ability, that business plan which convert expected revenues and future success of These statements involve a variety of risks and. Based inherent uncertainties and assumptions, the judgments with respect to future commercial, competition and the market conditions and future business decisions of, all of them difficult and impossible to predict accurately and many of these outside that check Milestone. Some of the major factors that could cause including, without limitation are set forth significantly from the forward-looking in the testimony, the general economic conditions, achieving the failures of the expected sales growth, change in our operating expenses, adverse patent conditions as well as sentences and FDA or legal developments, competition, amendments at customer and market requirements and standards in the risk factor, from time to time from time to time in periodic filings Milestone at of Securities and Exchange Commission, including, without limitation, Milestone ‘s Annual Report on Form 10-KSB of the year ended December 2006. The looking forward – statements are this release are based on reasonable beliefs of management as which date hereof Milestone takes no obligation be revised publicly any updates update publicly any forward-looking statements for some reason.